Taiflex Scientific : The Company's Board of Directors approved an investment to establish a subsidiary in Thailand

Close

Today's Information

Provided by: TAIFLEX Scientific Co.,Ltd
SEQ_NO	5	Date of announcement	2022/02/23	Time of announcement	18:08:10
Subject	The Company's Board of Directors approved an investment to establish a subsidiary in Thailand
Date of events	2022/02/23	To which item it meets	paragraph 20
Statement	1.Name and nature of the underlying assets (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield, etc.):Taiflex Scientific Thailand Co., Ltd.(tentative) 2.Date of occurrence of the event:2022/02/23 3.Amount, unit price, and total monetary amount of the transaction: It is estimated no more than US$ 35,000 thousands in total (around NT$ 980,000 thousands) 4.Trading counterparty and its relationship with the Company (if the trading counterparty is a natural person and furthermore is not a related party of the Company, the name of the trading counterparty is not required to be disclosed):Not applicable. 5.Where the trading counterparty is a related party, announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, its relationship with the Company and the trading counterparty, and the previous date and monetary amount of transfer: Newly established company; not applicable. 6.Where an owner of the underlying assets within the past five years has been a related party of the Company, the announcement shall also include the date and price of acquisition and disposal by the related party, and its relationship with the Company at the time of the transaction: Not applicable. 7.Matters related to the current disposal of creditors' rights (including types of collaterals of the disposed creditor's rights; if creditor's rights over a related party, announcement shall be made of the name of the related party and the book amount of the creditor's rights, currently being disposed of, over such related party):Not applicable. 8.Profit or loss from the disposal (not applicable in cases of acquisition of securities) (those with deferral should provide a table explaining recognition):Not applicable. 9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important terms and conditions:Capital injection based on the operational requirements. 10.The manner of deciding on this transaction (such as invitation to tender, price comparison, or price negotiation), the reference basis for the decision on price, and the decision-making unit: Based on the Board of Directors' resolution. 11.Net worth per share of the Company's underlying securities acquired or disposed of:Not applicable. 12.Cumulative no.of shares held (including the current transaction), their monetary amount, shareholding percentage, and status of any restriction of rights (e.g., pledges), as of the present moment: It is estimated no more than US$ 35,000 thousands (around NT$ 980,000 thousands)；shareholding percentage is 100%； status of any restriction of rights：none 13.Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing the Acquisition and Disposal of Assets by Public Companies) to the total assets and equity attributable to owners of the parent as shown in the most recent financial statement and working capital as shown in the most recent financial statement as of the present: To the total assets：10.55% To the equity attributable to owners of the parent：18.28% Working capital amount：NT$4,409,142 thousands 14.Broker and broker's fee:Not applicable. 15.Concrete purpose or use of the acquisition or disposal: Business development. 16.Any dissenting opinions of directors to the present transaction:None. 17.Whether the counterparty of the current transaction is a related party:Yes. 18.Date of the board of directors resolution:2022/02/23 19.Date of ratification by supervisors or approval by the Audit Committee:2022/02/23 20.Whether the CPA issued an unreasonable opinion regarding the current transaction:Not applicable. 21.Name of the CPA firm:Not applicable. 22.Name of the CPA:Not applicable. 23.Practice certificate number of the CPA:Not applicable. 24.Whether the transaction involved in change of business model:No. 25.Details on change of business model:Not applicable. 26.Details on transactions with the counterparty for the past year and the expected coming year:Not applicable. 27.Source of funds:Not applicable. 28.Any other matters that need to be specified:None.